what is expected:
DESCRIPTION
LSM3241: Bioinformatics and Biocomputing Lecture 1: Introduction Prof. Chen Yu Zong Tel: 6874-6877 Email: [email protected] http://xin.cz3.nus.edu.sg Room 07-24, level 7, SOC1, National University of Singapore. What is Expected:. To learn the most-widely used bioinformatics tools - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/1.jpg)
LSM3241: Bioinformatics and BiocomputingLSM3241: Bioinformatics and Biocomputing
Lecture 1: IntroductionLecture 1: Introduction
Prof. Chen Yu ZongProf. Chen Yu Zong
Tel: 6874-6877Tel: 6874-6877Email: Email: [email protected]@nus.edu.sghttp://xin.cz3.nus.edu.sghttp://xin.cz3.nus.edu.sg
Room 07-24, level 7, SOC1, Room 07-24, level 7, SOC1, National University of SingaporeNational University of Singapore
![Page 2: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/2.jpg)
22
What is Expected: What is Expected: To learn the most-widely used bioinformatics tools
• Basic understanding of the method in each tool (normally required in a college module)
• Capable of explaining the algorithm to a layperson (so that you are perceived as an expert!)
• Knowing the application range and limitation of each tool (now the real expert!)
To learn through real-case studies, focused on applications and problem solving:
• Lectures, labs, tutorials oriented toward real-case studies (we have an “open-lab” policy).
• Study of real and recently-emerged biological problems, virus research, drug design, systems biology (to give you the experience to work for a life-science lab or a pharmaceutical company).
![Page 3: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/3.jpg)
33
Labs, Exams and Textbook: Labs, Exams and Textbook: “Open-lab” policy:• Our lab assignments only uses internet tools and downloadable software
(which means that you can do the projects “any-time, any-place”)• You do not have to show-up in your lab, as long as you submit lab-report on
time.• Project-report submission system at:
http://bidd.nus.edu.sg/lsm3241/upload.htm
Exams:• 2 Projects (25% each), 1 Final (open-book, 50%).
Textbook:• As most of the topics are not covered by existing textbooks, you are not
required to have a textbook. The following are recommended reference books:– Introduction to Bioinformatics. Arthur M. Lesk. 2002. Oxford University Press;
ISBN: 0199251967– Bioinformatics: The Machine Learning Approach (Adaptive Computation and
Machine Learning). Pierre Baldi, Soren Brunak. 2001. The MIT Press; ISBN: 026202506X
– Molecular modelling : principles and applications. Andrew R. Leach. Imprint Harlow, England; Singapore:
![Page 4: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/4.jpg)
44
Topics covered: Topics covered:
Lecture 1: Introduction (week1):• Examples of bioinformatics tools applied to real-life
biological and drug design problems• Identification of SARS pathogen.• How a protein substrate escape?• Computer aided drug design
Lecture 2: Bioinformatics of viral genome (week2):• Viral genome database• Protein annotation.• Protein inhibitors.
Note: Please do not just listen. Get familiar with the biology-side of the topics in advance
![Page 5: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/5.jpg)
55
Topics covered: Topics covered: Lecture 3: Molecular database development (week3):• Protein inhibitor search• Getting chem-info about inhibitors.• 2D and 3D structures.• Database construction
Lecture 4: Sequence analysis (week4):• Sequence alignment methods revisited (pair-wise, BLAST,
MSA, PSI-BLAST)• Identification of a novel coronavirus as the SARS pathogen.
Project 1: Functional prediction of proteins in viral genomes by PSI-BLAST and SVM (25%) (week3-6)
Note: Please do not just listen. Get familiar with the biology-side of the topics in advance
![Page 6: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/6.jpg)
66
Topics covered: Topics covered: Lecture 5: Support vector machines for protein functionprediction (week5):• Support vector machines method for protein function
prediction• Use of SVMProt for protein function prediction.
Lecture 6: Fundamentals of molecular modeling (week6):• Structural organization of a molecule.• Basic interactions and models• Modeling methods (conformation search, energy
minimization)
Lecture 7: Modeling software (week7):• Learn to use a modeling software.
![Page 7: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/7.jpg)
77
Topics covered: Topics covered:
Lecture 8: Gene Expression profiles and microarray data analysis (week8)
Lecture 9: Clustering analysis of microarray data
Project 2: Clustering analysis of microarray data from GEO database
(25%) (week9-11).
Lecture 10: Biological pathway simulation
![Page 8: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/8.jpg)
88
Bioinformatics in Life Science Research Bioinformatics in Life Science Research and Drug Discovery: and Drug Discovery:
Examples:
• Identification of a novel coronavirus as the SARS pathogen.
• How a metabolite escape from a protein?• Design of anti-HIV drugs
Note: • Learn from these examples how bioinformatics tools can be used to
solve biological and drug design problems, which tool to use.• Also pay attention to the biological nature of each problem.
![Page 9: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/9.jpg)
99
SARS CoronavirusSARS CoronavirusA novel coronavirusIdentified as the cause ofsevere respiratorysyndrome (SARS )
![Page 10: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/10.jpg)
1010
SARS InfectionSARS Infection
How SARS coronavirus enters a cell and reproduce itself?
![Page 11: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/11.jpg)
1111
History of SARS EpidemicsHistory of SARS EpidemicsBig question in early stages:
What is the cause ofSARS ?
![Page 12: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/12.jpg)
1212
The Search of SARS pathogenThe Search of SARS pathogen
Suspect groups:
• A broad range of viral, bacterial, chlamydial,and rickettsial agents that likely to cause the SARS symptoms
Chief suspects:
• Versinia, mycoplasma, chlamydia, legionella, coxiella burnetii• spotted fever and typhus group rickettsiae,influenzaviruses A and B,
Paramyxovirinae and Pneumovirinae subfamily viruses (specifically, human respiratory syncytial virus and human metapneumovirus), Mastadenoviridae, Herpetoviridae,Picornaviridae, Old and New World hantaviruses, and Old World arenaviruses.
Consider yourself as a detective, how to solve a crime? Identify Suspect and Come up with Search Strategies
![Page 13: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/13.jpg)
1313
The Search of SARS pathogenThe Search of SARS pathogen
Traditional detection methods:
• Virus isolation in suckling mice and cell culture• Electron microscopy• Histopathological examination• Serologic analysis• General and specialized bacterial culture techniques
Molecular detection methods:
• Polymerase chain reaction (PCR)• Reverse-transcription PCR (RT-PCR)• Real-time PCRFollowed by sequence comparison with those of existing pathogens
New England Journal of Medicine 348, 1953-1966 (2003)
![Page 14: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/14.jpg)
1414
The Search of SARS pathogenThe Search of SARS pathogen
Findings from molecular detection:
• A 405-nucleotide segment of the coronavirus polymerase gene open reading frame 1b was amplified from the isolation material by RT-PCR with the broadly reactive primer set IN-2–IN-4. In contrast, this primer set produced no specific band against uninfected cells.
• When compared with other human and animal coronaviruses, the nucleotide and deduced amino acid sequence from this region had similarity scores ranging from 0.56 to 0.63 and from 0.57 to 0.74, respectively. The highest sequence similarity was obtained with group II coronaviruses.
New England Journal of Medicine 348, 1953-1966 (2003)
![Page 15: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/15.jpg)
1515
The Search The Search of SARS pathogenof SARS pathogen
• Sequence comparison identifies a novel coronavirus as the SARS pathogen
![Page 16: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/16.jpg)
1616
Sequence Comparison of Sequence Comparison of SARS coronavirus with othersSARS coronavirus with others
![Page 17: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/17.jpg)
1717
SARS Coronavirus GenomeSARS Coronavirus Genome
Get familiar with all the known genes (genome location, sequence, function. Where to get these info?
![Page 18: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/18.jpg)
1818
How can an enzyme metabolite escape?How can an enzyme metabolite escape?
The enzyme acetylcholinesterase generates a strong electrostatic field that can attract the cationic substrate acetylcholine to the active site.
However, the long and narrow active site gorge seems inconsistent with the enzyme's high catalytic rate.
E + S E + P
How does the metabolite P escape?
Acetylcholinesterase (AChE) is the enzyme responsible for the termination of signaling in cholinergic synapses (such as the neuromuscular junction) by degrading the neurotransmitter acetylcholine. AChE has a gorge, 2 nm deep, leading to the catalytic site
![Page 19: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/19.jpg)
1919
How can an enzyme metabolite escape?How can an enzyme metabolite escape?
Metabolite unlikely escape through the entrance
How can it escape?
![Page 20: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/20.jpg)
2020
How can an enzyme metabolite escape?How can an enzyme metabolite escape?
How can it escape?
Can you tell which of the following possibilities is likely or unlikely, and why?
Protein unfolding
Condensation of ions on protein surface to counter-balance the force
Change of electric charge on metabolite
Alternative escape route
![Page 21: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/21.jpg)
2121
How can an enzyme metabolite escape?How can an enzyme metabolite escape?
Alternative route
An “open back door” policy:
Transient opening of a channel to allow the metabolite to escape
![Page 22: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/22.jpg)
2222
Protein structureProtein structureFrom static view to dynamic viewFrom static view to dynamic view
Protein should not be viewed as a static structure
Protein flexibility is an intrinsic feature of enormous biological significance
![Page 23: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/23.jpg)
2323
Modeling of protein motion Modeling of protein motion by molecular dynamics simulationby molecular dynamics simulation
Protein motion can be simulated by means of molecular dynamics simulations:
Trajectory of atom movement is determined by Newton’s second law:
F=ma
x(t)=x(0)+vt+1/2 a t2
Typical MD software:
AMBER, CHARM, TINKER
TINKER is freely downloadable
![Page 24: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/24.jpg)
2424
MD simulation of acetylcholinesterase MD simulation of acetylcholinesterase
MD simulation clearly reveals transient opening of a channel “back door”
Science 263, 1276-1278 (1994)
The open “back door”allows the metabolite Pto escape
![Page 25: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/25.jpg)
2525
Design of anti-HIV drugs Design of anti-HIV drugs
HIV virus structure
![Page 26: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/26.jpg)
2626
Design of anti-HIV drugs Design of anti-HIV drugs
HIV viral genome
![Page 27: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/27.jpg)
2727
Design of anti-HIV drugs Design of anti-HIV drugs
Recognition
of HIV infected cell
Vaccine-based drugs
![Page 28: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/28.jpg)
2828
Design of anti-HIV drugs Design of anti-HIV drugs Pathways of HIV infection and reproduction and sites of drug action
![Page 29: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/29.jpg)
2929
Design of anti-HIV drugs Design of anti-HIV drugs
Pathways of HIV infection and reproduction and sites of drug action
![Page 30: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/30.jpg)
3030
Design of anti-HIV drugs Design of anti-HIV drugs
Selection of a target: HIV-1 protease
![Page 31: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/31.jpg)
3131
Design of anti-HIV drugs Design of anti-HIV drugs
HIV-1 protease structure and cavity
![Page 32: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/32.jpg)
3232
Design of anti-HIV drugs Design of anti-HIV drugs
Drug and protein:
Lock and key mechanism, blocking=>stopping of protein function
![Page 33: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/33.jpg)
3333
Design of anti-HIV drugsDesign of anti-HIV drugs
![Page 34: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/34.jpg)
3434
Design of anti-HIV drugsDesign of anti-HIV drugs
Drug design:
• Step 1: Finding the right target in the genome
• A key protein involved in viral cycle (stop the disease process)
• Different from human proteins (reduce side-effects)
• Step 2: Finding or making a chemical agent to stop the protein
• In majority of cases: protein inhibitors
• Step 3: Test and clinical trials
![Page 35: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/35.jpg)
3535
..Design of HIV-1 Protease InhibitorDesign of HIV-1 Protease Inhibitor
![Page 36: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/36.jpg)
3636
..Design of HIV-1 Protease InhibitorDesign of HIV-1 Protease Inhibitor
![Page 37: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/37.jpg)
3737
..Design of HIV-1 Protease InhibitorDesign of HIV-1 Protease Inhibitor
![Page 38: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/38.jpg)
3838
..Design of HIV-1 Protease InhibitorDesign of HIV-1 Protease Inhibitor
![Page 39: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/39.jpg)
3939
Success Stories:Success Stories:
• HIV-1 Protease Inhibitors in the market:– Inverase (Hoffman-LaRoche, 1995)– Norvir (Abbot, 1996)– Crixivan (Merck, 1996)– Viracept (Agouron, 1997)
Drug discovery today 2, 261-272 (1997)
![Page 40: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/40.jpg)
4040
Design of anti-SARS drugsDesign of anti-SARS drugs
Pathways of SARS infection and reproduction and sites of drug action.
Research works underway
But the efforts have cooled down due to the “elimination” of this virus
![Page 41: What is Expected:](https://reader035.vdocuments.site/reader035/viewer/2022081513/56814535550346895db1fedb/html5/thumbnails/41.jpg)
4141
Summary of Today’s lectureSummary of Today’s lecture
• Bioinformatics tools in real-life biological research and drug design problems
• Tools include:– Sequence analysis– Microarray data analysis (relatively new, not covered)– Molecular modeling– Computer-aided drug design